Suppr超能文献

伴有高分子量形式促肾上腺皮质激素分泌的亚临床库欣病

Subclinical Cushing's Disease with High-Molecular-Weight Forms of Adrenocorticotropic Hormone Production.

作者信息

Inukai Takahiko, Harai Nozomi, Nakagawa Yukie, Hosokawa Tadatsugu, Antoku Airi, Muroi Yuko, Ogiwara Masakazu, Tsuchiya Kyoichiro

机构信息

Department of Diabetes and Endocrinology, University of Yamanashi Hospital, Yamanashi, Japan.

Department of Neurosurgery, University of Yamanashi Hospital, Yamanashi, Japan.

出版信息

Case Rep Endocrinol. 2024 Mar 25;2024:8721614. doi: 10.1155/2024/8721614. eCollection 2024.

Abstract

Production of the high-molecular-weight forms of adrenocorticotropic hormone (big-ACTH) has been reported in a small number of ectopic ACTH syndrome and ACTH-producing pituitary macroadenoma. However, perioperative changes in big-ACTH in patients with subclinical Cushing's disease have not been reported. A 63-year-old woman presented 25 × 20 × 20-mm-sized macroadenoma in the pituitary gland. Her early morning plasma ACTH and cortisol levels were 111 pg/mL and 11.6 g/dL, respectively. Cushingoid features and diurnal variation in plasma cortisol levels were not observed. The patient's urinary free cortisol (UFC) was 59.3 g/day. The corticotropin-releasing hormone (CRH) test showed that plasma ACTH levels were 1.5 times higher than the preload value. The overnight dexamethasone suppression test (DST) showed that the plasma cortisol level was not suppressed by 0.5 mg of dexamethasone (DEX) but was suppressed by 8 mg of DEX. Inferior pyramidal sinus sampling was consistent with Cushing's disease. Taken together, the patient was clinically diagnosed with subclinical Cushing's disease caused by an ACTH-producing pituitary adenoma. Endoscopic transsphenoidal adenomectomy was performed. In the postoperative CRH test, plasma ACTH levels showed six-fold increase. The postoperative DST showed cortisol suppression at 0.5 mg of DEX. The UFC levels decreased to 35.1 g/day. Pituitary contrast-enhanced MRI revealed no residual tumor, and plasma ACTH and cortisol levels remained within normal ranges. Gel filtration of preoperative and postoperative plasma ACTH was performed, and a high molecular weight fraction of ACTH was detected, which markedly decreased postoperatively. The absence of Cushingoid features and the lack of significant cortisol hypersecretion in this case were thought to be due in part to big-ACTH, which has low bioactivity. By careful evaluation of laboratory and clinical findings, we identified it as a big-ACTH-producing adenoma. This is the first report of a case in which the big-ACTH transition was observed perioperative and is a valuable case.

摘要

少数异位促肾上腺皮质激素(ACTH)综合征和分泌ACTH的垂体大腺瘤中曾有高分子量形式促肾上腺皮质激素(大ACTH)产生的报道。然而,亚临床库欣病患者围手术期大ACTH的变化尚未见报道。一名63岁女性,垂体有一个大小为25×20×20mm的大腺瘤。其清晨血浆ACTH和皮质醇水平分别为111pg/mL和11.6μg/dL。未观察到库欣样特征和血浆皮质醇水平的昼夜变化。患者尿游离皮质醇(UFC)为59.3μg/天。促肾上腺皮质激素释放激素(CRH)试验显示血浆ACTH水平比负荷前值高1.5倍。过夜地塞米松抑制试验(DST)显示,0.5mg地塞米松(DEX)未抑制血浆皮质醇水平,但8mg DEX可抑制。垂体下静脉窦采血结果与库欣病相符。综合判断,该患者临床诊断为分泌ACTH的垂体腺瘤所致亚临床库欣病。实施了内镜经蝶窦腺瘤切除术。术后CRH试验中,血浆ACTH水平升高了6倍。术后DST显示0.5mg DEX可抑制皮质醇。UFC水平降至35.1μg/天。垂体增强磁共振成像(MRI)未显示残留肿瘤,血浆ACTH和皮质醇水平仍在正常范围内。对术前和术后血浆ACTH进行凝胶过滤,检测到ACTH的高分子量部分,术后该部分显著减少。该病例中未出现库欣样特征且无明显皮质醇分泌过多,部分原因被认为是生物活性较低的大ACTH所致。通过仔细评估实验室和临床检查结果,我们将其鉴定为分泌大ACTH的腺瘤。这是首例围手术期观察到大ACTH转变的病例报告,具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/da66/10985640/a5d7fd9de716/CRIE2024-8721614.001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验